Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 301


A combination of the on-treatment FIB-4 and alpha-foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir.

Chiang HH, Lee CM, Hu TH, Hung CH, Wang JH, Lu SN, Lai HC, Su WP, Lin CH, Peng CY, Chen CH.

Liver Int. 2018 May 24. doi: 10.1111/liv.13889. [Epub ahead of print]


Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro.

Su WP, Sun LN, Yang SL, Zhao H, Zeng TY, Wu WZ, Wang D.

J Biochem Mol Toxicol. 2018 May 2:e22158. doi: 10.1002/jbt.22158. [Epub ahead of print]


Excellent treatment response with pembrolizumab in a lung cancer patient who developed immune-mediated acute motor/sensory axonal polyneuropathy.

Yen CC, Su HC, Chu CY, Lai SJ, Yan JJ, Su WP, Su WC.

Lung Cancer. 2018 Jun;120:149-151. doi: 10.1016/j.lungcan.2018.04.014. Epub 2018 Apr 17. No abstract available.


Publisher Correction: New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis.

Wang HW, Peng CY, Lai HC, Su WP, Lin CH, Chuang PH, Chen SH, Chen CH, Hsu WF, Huang GT.

Sci Rep. 2018 Apr 11;8(1):6062. doi: 10.1038/s41598-018-24186-5.


Curcumin attenuates heat-stress-induced oxidant damage by simultaneous activation of GSH-related antioxidant enzymes and Nrf2-mediated phase II detoxifying enzyme systems in broiler chickens.

Zhang JF, Bai KW, Su WP, Wang AA, Zhang LL, Huang KH, Wang T.

Poult Sci. 2018 Apr 1;97(4):1209-1219. doi: 10.3382/ps/pex408.


Changes in liver stiffness measurement using acoustic radiation force impulse elastography after antiviral therapy in patients with chronic hepatitis C.

Chen SH, Lai HC, Chiang IP, Su WP, Lin CH, Kao JT, Chuang PH, Hsu WF, Wang HW, Chen HY, Huang GT, Peng CY.

PLoS One. 2018 Jan 2;13(1):e0190455. doi: 10.1371/journal.pone.0190455. eCollection 2018.


Improving the convergence rate of a hybrid input-output phasing algorithm by varying the reflection data weight.

He H, Su WP.

Acta Crystallogr A Found Adv. 2018 Jan 1;74(Pt 1):36-43. doi: 10.1107/S205327331701436X. Epub 2018 Jan 1.


Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir.

Chen CH, Lee CM, Lai HC, Hu TH, Su WP, Lu SN, Lin CH, Hung CH, Wang JH, Lee MH, Peng CY.

Oncotarget. 2017 Sep 28;8(54):92431-92441. doi: 10.18632/oncotarget.21369. eCollection 2017 Nov 3.


Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial.

Petrylak DP, de Wit R, Chi KN, Drakaki A, Sternberg CN, Nishiyama H, Castellano D, Hussain S, Fléchon A, Bamias A, Yu EY, van der Heijden MS, Matsubara N, Alekseev B, Necchi A, Géczi L, Ou YC, Coskun HS, Su WP, Hegemann M, Percent IJ, Lee JL, Tucci M, Semenov A, Laestadius F, Peer A, Tortora G, Safina S, Del Muro XG, Rodriguez-Vida A, Cicin I, Harputluoglu H, Widau RC, Liepa AM, Walgren RA, Hamid O, Zimmermann AH, Bell-McGuinn KM, Powles T; RANGE study investigators.

Lancet. 2017 Nov 18;390(10109):2266-2277. doi: 10.1016/S0140-6736(17)32365-6. Epub 2017 Sep 12.


Trajectories of serum hepatitis B surface antigen kinetics in patients with chronic hepatitis B receiving long-term nucleos(t)ide analogue therapy.

Hsu WF, Chen CF, Lai HC, Su WP, Lin CH, Chuang PH, Chen SH, Chen CH, Wang HW, Huang GT, Peng CY.

Liver Int. 2018 Apr;38(4):627-635. doi: 10.1111/liv.13564. Epub 2017 Sep 15.


Does pyogenic liver abscess increase the risk of delayed-onset primary liver cancer?: Evidence from a nationwide cohort study.

Chu CS, Lin CC, Peng CY, Chuang PH, Su WP, Lai SW, Chen HJ, Chung CJ, Lai HC.

Medicine (Baltimore). 2017 Aug;96(34):e7785. doi: 10.1097/MD.0000000000007785.


Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways.

Su WP, Ho YC, Wu CK, Hsu SH, Shiu JL, Huang JC, Chang SB, Chiu WT, Hung JJ, Liu TL, Wu WS, Wu PY, Su WC, Chang JY, Liaw H.

Sci Rep. 2017 Jun 20;7(1):3879. doi: 10.1038/s41598-017-04223-5.


Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients.

Lee MH, Huang CF, Lai HC, Lin CY, Dai CY, Liu CJ, Wang JH, Huang JF, Su WP, Yang HC, Kee KM, Yeh ML, Chuang PH, Hsu SJ, Huang CI, Kao JT, Chen CC, Chen SH, Jeng WJ, Yang HI, Yuan Y, Lu SN, Sheen IS, Liu CH, Peng CY, Kao JH, Yu ML, Chuang WL, Chen CJ.

Sci Rep. 2017 Jun 16;7(1):3718. doi: 10.1038/s41598-017-02313-y.


New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis.

Wang HW, Peng CY, Lai HC, Su WP, Lin CH, Chuang PH, Chen SH, Chen CH, Hsu WF, Huang GT.

Sci Rep. 2017 Jun 12;7(1):3259. doi: 10.1038/s41598-017-03589-w. Erratum in: Sci Rep. 2018 Apr 11;8(1):6062.


Correlations of ALDH2 rs671 and C12orf30 rs4767364 polymorphisms with increased risk and prognosis of esophageal squamous cell carcinoma in the Kazak and Han populations in Xinjiang province.

Liu P, Zhao HR, Li F, Zhang L, Zhang H, Wang WR, Mao R, Su WP, Zhang Y, Bao YX.

J Clin Lab Anal. 2018 Feb;32(2). doi: 10.1002/jcla.22248. Epub 2017 May 2.


Effect of EBI3 on radiation-induced immunosuppression of cervical cancer HeLa cells by regulating Treg cells through PD-1/PD-L1 pathway.

Zhang SA, Niyazi HE, Hong W, Tuluwengjiang GL, Zhang L, Zhang Y, Su WP, Bao YX.

Tumour Biol. 2017 Mar;39(3):1010428317692237. doi: 10.1177/1010428317692237.


Effects of miRNA-143 and the non-coding RNA MALAT1 on the pathogenesis and metastasis of HeLa cells.

Zhang L, Niyazi HE, Zhao HR, Cao XP, Abudula MN, Ye WJ, Zhang SA, Yiming RH, Zhang Y, Su WP, Chen R, Ouyang Y, Miao N, Bao YX.

Genet Mol Res. 2017 Feb 23;16(1). doi: 10.4238/gmr16019269.


Early hepatitis B surface antigen decline predicts treatment response to entecavir in patients with chronic hepatitis B.

Peng CY, Lai HC, Su WP, Lin CH, Chuang PH, Chen SH, Chen CH.

Sci Rep. 2017 Feb 21;7:42879. doi: 10.1038/srep42879.


HYAL-2-WWOX-SMAD4 Signaling in Cell Death and Anticancer Response.

Hsu LJ, Chiang MF, Sze CI, Su WP, Yap YV, Lee IT, Kuo HL, Chang NS.

Front Cell Dev Biol. 2016 Dec 6;4:141. doi: 10.3389/fcell.2016.00141. eCollection 2016. Review.

Supplemental Content

Support Center